Semaglutide 5mg — Vial Spec, Reconstitution Math & COA

Overview of Semaglutide 5mg Vial Specifications

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist featuring a modified amino acid sequence that includes a C18 fatty diacid chain attached via a hydrophilic spacer. In laboratory settings, the 5mg lyophilized vial format serves as a standardized unit of measure for bench science. This specific mass allows investigators to prepare operational stock solutions at precise molarities required for high-throughput screening or multi-week preclinical research runs.

When purchasing laboratory compounds, researchers must evaluate fill weight precision and cake structural integrity. The 5mg lyophilized cake is preserved under vacuum or inert nitrogen gas to shield the peptide backbone from atmospheric oxidation and moisture degradation. PX1 Research provides fully characterized research compounds to ensure consistency across baseline controls and active treatment arms. Research labs evaluating our catalog can browse our complete inventory via all peptides to compare available mass configurations and study options.

Reconstitution Mathematics: 1 mL, 2 mL, and 3 mL Diluent Calculations

Accurate concentration calculations are vital when preparing Semaglutide 5mg for volumetric measurements in assay protocols. Depending on the assay sensitivity and working volume requirements, investigators typically select between 1.0 mL, 2.0 mL, or 3.0 mL of bacteriostatic water (0.9% benzyl alcohol) or sterile physiological saline as the diluent.

When 1.0 mL of diluent is introduced to a 5mg vial, the resulting stock concentration is exactly 5.0 mg/mL (5,000 µg/mL). For micro-pipetting into cell culture media or microplate wells, 10 µL of this stock yields 50 µg of active peptide. Based on Semaglutide's approximate molecular weight of 4113.58 g/mol, a 5.0 mg/mL concentration corresponds to a molar concentration of approximately 1.215 mM (millimolar).

Introducing 2.0 mL of diluent yields a final working concentration of 2.5 mg/mL (2,500 µg/mL), or roughly 0.608 mM. This concentration is frequently preferred for preclinical animal studies where administration volumes must be scaled accurately to animal body weights without introducing volumetric pipetting errors. If 3.0 mL of diluent is added, the final stock concentration decreases to 1.667 mg/mL (1,666.7 µg/mL), or approximately 0.405 mM, which is useful when larger working volumes are required for manual dosing setups. Researchers can easily calculate customized solvent-to-solute ratios using our interactive laboratory reconstitution calculator.

Reconstitution Protocol and Aliquoting Planning

To maintain peptide integrity during reconstitution, laboratory technicians should adhere to standard biochemical handling procedures. Diluent must be introduced slowly along the glass wall of the vial using a sterile needle or pipette, allowing the liquid to trickle down into the lyophilized cake. Direct high-pressure stream impingement onto the lyophilized powder should be avoided, as forced agitation can disrupt tertiary structure and induce peptide aggregation.

Once the diluent is added, gently swirl the vial until the cake is completely dissolved into a clear, colorless solution. The vial should never be vigorously shaken or vortexed. Following complete dissolution, stock solutions should be immediately aliquoted into sterile, low-binding microcentrifuge tubes. Aliquoting prevents the degradation associated with repeated freeze-thaw cycles. Each aliquot should reflect the volumetric volume required for a single experimental assay or daily study protocol.

Molecular Mechanism and Receptor Affinity Profile in Preclinical Models

In vitro assays indicate that Semaglutide functions as a potent agonist at the GLP-1 receptor, demonstrating high affinity for the extracellular domain of the G protein-coupled receptor. The structural inclusion of an alpha-aminoisobutyric acid (Aib) residue at position 8 confers resistance to enzymatic cleavage by dipeptidyl peptidase-4 (DPP-4). Furthermore, the conjugated C18 fatty diacid facilitates reversible binding to serum albumin, substantially extending the peptide's structural half-life in physiological media.

Preclinical rodent models suggest that activation of central and peripheral GLP-1 pathways modulates intracellular cyclic adenosine monophosphate (cAMP) accumulation, intracellular calcium influx, and downstream signaling cascades involving protein kinase A (PKA). Studies examining metabolic and gut peptide signaling pathways often compare GLP-1 receptor dynamics with dual- or multi-agonist peptides, such as dual GLP-1/GIP receptor targets or specific gut axis regulators like GLP-2 receptor targets, to map overlapping signaling networks.

Storage, Stability, and Freeze-Thaw Mitigations

Lyophilized Semaglutide 5mg vials should be stored in a controlled freezer environment at -20°C to -80°C upon receipt to ensure long-term chemical stability. Protected from light and atmospheric moisture, the un-reconstituted peptide retains structural purity for up to 24 months. Storage at standard refrigeration temperature (2°C to 8°C) is acceptable for short-term handling, provided the container seal remains uncompromised.

Following reconstitution with bacteriostatic water, liquid stock solutions maintain analytical stability for up to 28 days when refrigerated between 2°C and 8°C. If non-preserved sterile saline or water for injection is utilized, the reconstituted solution must be used immediately or aliquoted and flash-frozen at -80°C. Frozen aliquots should be thawed slowly on ice prior to testing; repeated temperature cycling above and below 0°C accelerates peptide degradation via physical shear forces and ice crystal formation.

Lot-Matched COA, HPLC, MS, and Endotoxin Testing Standards

Rigorous quality control is essential for reproducible scientific research. Every batch of Semaglutide supplied by PX1 Research undergoes strict analytical testing by ISO 17025 accredited third-party laboratories. Quality verification includes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 99%, along with Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight match to the theoretical mass of 4113.58 Da.

Additionally, analytical verification includes testing for residual solvents, counter-ion mass balance, and bacterial endotoxin levels via Limulus Amebocyte Lysate (LAL) assays per USP <85> guidelines. Endotoxin limits are maintained strictly below 0.01 EU/mg to eliminate confounding immune activation factors in cell culture assays or preclinical animal models. Investigators can review detailed lot-specific test results on our dedicated certificate of analysis hub.

Comparative Analysis: Semaglutide 5mg vs. Related Incretin Mimetics

When designing metabolic research projects, investigators often evaluate Semaglutide alongside other prominent incretin mimetics to contrast single-receptor activation against multi-target agonism. Understanding how peptide structure alters binding kinetics and downstream intracellular signaling pathways allows researchers to select the exact agent required for their theoretical model.

For instance, researchers frequently analyze tirzepatide research studies to compare mono-agonist GLP-1 signaling with dual GLP-1 and GIP receptor co-agonism. Similarly, studies investigating triple-agonist profiles incorporate retatrutide preclinical data alongside single-target peptides to quantify additive metabolic signaling. For historical baseline comparisons, older single-target agonists such as liraglutide research compounds offer a clear benchmark for shorter half-life receptor kinetics. Further comparative studies and published literature reviews are accessible via our central research library hub.

Vial Sizing Strategy: Evaluating 5mg vs. Alternative Lyophilized Mass Options

Selecting the proper vial mass configuration is a critical operational decision for laboratory managers. A 5mg vial size represents an ideal middle ground for medium-throughput applications, minimizing the total number of reconstitutions while preventing compound waste. If an assay requires minimal total peptide—such as preliminary binding affinity screens—a smaller 2mg fill mass may reduce long-term reconstituted storage risks.

Conversely, large-scale rodent cohorts or extended longitudinal studies may demand higher throughput single-lot batches. In these scenarios, high-volume research facilities often opt for 10mg or 20mg fill sizes, or establish bulk supply agreements. Institutional buyers looking to scale their assay capacity while maintaining single-lot consistency across extended protocols can submit requests through our wholesale lab account portal. If a specific target mass is currently unlisted in our standard catalog, our team provides alternative batch sizing to accommodate laboratory requirements.

Quality Assurance and PX1 Research Standards

PX1 Research is committed to serving the scientific community with USA-manufactured research peptides produced under strict GMP-compliant quality management systems. By enforcing stringent purity protocols, lot-matched analytical testing, and cold-chain storage standards, PX1 ensures that researchers receive consistent, stable, and highly characterized materials.

Every product shipped from our California and Arizona fulfillment centers is backed by complete batch transparency, ensuring that laboratory data remains valid and reproducible across independent trial runs. For deeper technical specifications on GLP-1 analogues, explore our in-depth semaglutide research guide.